Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAntonis C. Antoniou, Douglas F. Easton, Paul D.P. Pharoah et al.|The American Journal of Human Genetics|2003Cited by 3.7k
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerCharles E. Geyer, Tanja Španić, Judy E. Garber et al.|Annals of Oncology|2022Cited by 461
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsGöran Jönsson, Åke Borg, Johan Staaf et al.|Breast Cancer Research|2010Cited by 194
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genesNiklas Loman, Oskar T. Johannsson, P�r-Ola Bendahl et al.|Cancer|1998Cited by 180
Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriersOskar T. Johannsson, Håkan Olsson, Niklas Loman et al.|The Lancet|1998Cited by 134